UCB Australia leadership team

"In Australia, UCB has been serving patients in need for more than 20 years. Today, our commitment to the Australian community has never been stronger. We see a growing need to provide new differentiated treatment options to people living with epilepsy and rare epilepsy syndromes, rare neurological diseases and chronic inflammatory diseases"
Selina Clifford
General Manager and Head of Rare Disease & Epilepsy Patient Value Unit
Joined UCB in 2008

"As an Australian leadership team we aim to create a high-performing and engaging work environment, but this success is an affiliate effort. The dedication of our entire team has led to our recognition as an Employer of Choice by The Australian Business Awards® for two years in a row. As the Health of the Planet Committee spons or, I've worked with passionate employees to implement initiatives like our electric vehicle policy, shifting international freight from air to ocean, and promoting employee volunteering and education programs."
Craig Braithwaite
Head of I2I Patient Impact Intercontinental East
Joined UCB in 2021

"We draw from our global strengths to provide solutions for patients suffering from chronic inflammatory conditions and have provided solutions for women of child-bearing age with chronic rheumatic diseases looking to start or expand their family. As sponsor of the Diversity Equity and Inclusion Committee, I help ensure we live a culture of inclusion. We understand the value of equitable opportunities and we are proud of the 62% female gender balance at UCB Australia."
Francesca Bianco
Head of Immunology Patient Value Unit
Joined UCB in 2013

"We are focused on ensuring that all Australians will have access to global UCB treatment options, by registering them with the Therapeutic Goods Administration. We support the Stronger PBS Campaign, developed by Medicines Australia, to help improve access to medicines for all Australians."
Anna Argyropoulos
Head of Regulatory, Ethics & Compliance
Joined UCB in 2006

"Our priority is to secure timely PBS reimbursement to UCB’s innovative medicines for Australians living with severe diseases, particularly in areas of high unmet clinical need.”
Penny Lovell
Head of Access, Sustainability and External Engagement
Joined UCB in 2023
AU-OT-2400019. May 2025.